When detection of soft tissue metastases becomes more important in the primary staging of prostate cancer, given the options to treat oligo metastatic disease, PET/CT with other tracers, for example 68Ga- or 18F-PSMA, would probably be more suited than NaF PET/CT. Here, FOLH1 is linked to prostate cancer.